PharmaCorp Rx Inc. (PCRX : TSX-V)
Common Stock
$0.52
CAD
+0.01 (1.96%)
Last updated: 2026-06-02
PCRX
PharmaCorp Rx Inc.
Performance
1 Day
+1.96%
1 Week
+1.96%
1 Month
+6.12%
YTD
+8.33%
Key Statistics
Market Cap
$88.78M
52W High
$0.58
52W Low
$0.40
P/E Ratio
-
50 Day MA
$0.46
200 Day MA
$0.46
Beta
-4.30
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/2/2026 | $0.50 | $0.52 | $0.50 | $0.52 | $0.52 | 40,000 |
| 6/1/2026 | $0.53 | $0.53 | $0.50 | $0.51 | $0.51 | 26,241 |
| 5/29/2026 | $0.50 | $0.51 | $0.50 | $0.51 | $0.51 | 67,000 |
| 5/28/2026 | $0.50 | $0.51 | $0.49 | $0.50 | $0.50 | 735,250 |
| 5/27/2026 | $0.52 | $0.52 | $0.50 | $0.50 | $0.50 | 39,700 |
| 5/26/2026 | $0.52 | $0.52 | $0.51 | $0.51 | $0.51 | 60,524 |
| 5/25/2026 | $0.48 | $0.53 | $0.48 | $0.52 | $0.52 | 256,244 |
| 5/22/2026 | $0.48 | $0.48 | $0.48 | $0.48 | $0.48 | 95,850 |
| 5/21/2026 | $0.47 | $0.48 | $0.47 | $0.48 | $0.48 | 49,000 |
| 5/20/2026 | $0.47 | $0.47 | $0.47 | $0.47 | $0.47 | 81,900 |
Analyst Price Targets
Based on analyst covering PCRX
Wall Street analysts forecast PCRX stock price to rise 34.6% over the next 12 months.
Consensus
No RatingAvg. Target
C$0.70
+34.6% Upside
Current Price
C$0.52
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PCRX's historical volatility
30-Day Vol
65.5%
Annualized
90-Day Vol
49.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.62
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.55 | C$0.44 โ C$0.69 |
| 60 trading days | C$0.59 | C$0.43 โ C$0.81 |
| 90 trading days | C$0.62 | C$0.42 โ C$0.92 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About PharmaCorp Rx Inc.
PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health products, and wellness items; custom compounding; specialized consultations; and lifestyle programs. PharmaCorp Rx Inc. was incorporated in 2021 and is headquartered in Saskatoon, Canada.
Financials
- Revenue (TTM)
- $20.89M
- EBITDA
- $-414,759
- Profit Margin
- -7.09%
- ROE (TTM)
- -3.43%
- EPS (Diluted)
- -0.01
- Book Value
- 0.30
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE Report